US To Zero Out Tariffs On UK Pharma Under Trade Deal [Barron's]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Barrons
tariffs under a unique deal which sees the UK increase spending on American drugs by 25 percent. The accord aims to "address long-standing imbalances in US-UK pharmaceutical trade," ending what US trade ambassador Jamieson Greer called an arrangement where "American patients have been forced to subsidise prescription drugs and biologics in other developed countries." Advertisement - Scroll to Continue Under the deal struck between the administrations of US President Donald Trump and British Prime Minister Keir Starmer, Britain's publicly-funded National Health Service (NHS) will increase its prices for new US treatments by 25 percent. The agreement means Britain will be exempted from hefty US tariffs imposed on pharma imports that entered force on October 1. It is the only country to reach such a deal. The lofty price of medications has been a major political issue in the United States for years, with a Rand Corporation study showing Americans paid 2.5 times as much for phar
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- China's Licensing Trends Shaping Global Drug Development Analysis Report 2025: Parent Companies Benefitted from Upfront Payments for R&D, Gaining Equity in Novel Chinese Therapeutics [Yahoo! Finance]Yahoo! Finance
- Has AstraZeneca's Strong 30% Rally Left Further Upside in 2025? [Yahoo! Finance]Yahoo! Finance
- Massive U.S. drug spending gives Trump trade leverage [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- AstraZeneca advances hematology and cell therapy ambition with largest-ever presence at ASHBusiness Wire
- Why Astrazeneca (AZN) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 12/4/25 - Form 6-K
- 12/1/25 - Form 6-K
- 12/1/25 - Form 6-K
- AZN's page on the SEC website